AI Insight
A Danish national randomized controlled trial investigated whether placing left ventricular pacing leads at the site of latest electrical activation would improve outcomes in heart failure patients with prolonged QRS compared to conventional posterolateral placement. The study found no significant reduction in the composite endpoint of death or unplanned heart failure hospitalization with the targeted placement approach. Both lead placement strategies showed similar clinical outcomes in this biventricular pacing study.
Why it matters
This trial challenges the assumption that individualized, electrophysiology-guided lead placement offers superior outcomes over conventional anatomical positioning in cardiac resynchronization therapy. The findings suggest that the standard posterolateral approach remains a valid and simpler strategy for clinicians treating heart failure patients requiring biventricular pacing devices.
Understand the Science
In patients with heart failure and prolonged QRS, targeted left ventricular lead placement at the site of latest electrical activation did not reduce the composite endpoint of death or unplanned hospitalisation for heart failure compared with conventional lead placement in a posterolateral, non-apical position.